Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
about
KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review.Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.PML down-regulation in soft tissue sarcomas.Prognostic impact of circulating tumor cells in patients with ampullary cancer.
P2860
Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Promyelocytic leukemia (PML) g ...... in ampullary cancer patients.
@en
type
label
Promyelocytic leukemia (PML) g ...... in ampullary cancer patients.
@en
prefLabel
Promyelocytic leukemia (PML) g ...... in ampullary cancer patients.
@en
P2093
P2860
P50
P356
P1433
P1476
Promyelocytic leukemia (PML) g ...... r in ampullary cancer patients
@en
P2093
B Vincenzi
F M Vecchio
P Magistrelli
P2860
P356
10.1093/ANNONC/MDN558
P50
P577
2008-08-09T00:00:00Z